Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7, 40

Mouse Genetic Models of Human Brain Disorders


Mouse Genetic Models of Human Brain Disorders

Celeste Leung et al. Front Genet.


Over the past three decades, genetic manipulations in mice have been used in neuroscience as a major approach to investigate the in vivo function of genes and their alterations. In particular, gene targeting techniques using embryonic stem cells have revolutionized the field of mammalian genetics and have been at the forefront in the generation of numerous mouse models of human brain disorders. In this review, we will first examine childhood developmental disorders such as autism, intellectual disability, Fragile X syndrome, and Williams-Beuren syndrome. We will then explore psychiatric disorders such as schizophrenia and lastly, neurodegenerative disorders including Alzheimer's disease and Parkinson's disease. We will outline the creation of these mouse models that range from single gene deletions, subtle point mutations to multi-gene manipulations, and discuss the key behavioral phenotypes of these mice. Ultimately, the analysis of the models outlined in this review will enhance our understanding of the in vivo role and underlying mechanisms of disease-related genes in both normal brain function and brain disorders, and provide potential therapeutic targets and strategies to prevent and treat these diseases.

Keywords: behavior; brain disorders; gene targeting; genetic models; inducible; knock-in; knockout; transgenic mice.

Similar articles

See all similar articles

Cited by 9 articles

See all "Cited by" articles


    1. Abazyan S., Pletnikov M. V. (2014). “Schizophrenia,” in Behavioural Genetics of the Mouse: Genetic Mouse Models of Neurobehavioral Disorders eds Pietropaolo F. S. S., Crusio W. E., editors. (Cambridge: Cambridge University Press; ) 189–207.
    1. Ahn T. B., Kim S. Y., Kim J. Y., Park S. S., Lee D. S., Min H. J., et al. (2008). alpha-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 70 43–49. 10.1212/01.wnl.0000271080.53272.c7 - DOI - PubMed
    1. Allen K. M., Gleeson J. G., Bagrodia S., Partington M. W., MacMillan J. C., Cerione R. A., et al. (1998). PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20 25–30. 10.1038/1675 - DOI - PubMed
    1. Amiri A., Sanchez-Ortiz E., Cho W., Birnbaum S. G., Xu J., McKay R. M., et al. (2014). Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus. Autism Res. 7 60–71. 10.1002/aur.1342 - DOI - PubMed
    1. Anderson G. R., Galfin T., Xu W., Aoto J., Malenka R. C., Sudhof T. C. (2012). Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc. Natl. Acad. Sci. U.S.A. 109 18120–18125. 10.1073/pnas.1216398109 - DOI - PMC - PubMed